Defense Minister Benny Gantz was briefed on the progress made by the Institute for Biological Research last week in developing a vaccine that is likely to be tested in humans from October 21, the WallaNews news site said on Sunday. .
At the moment, the development of the vaccine is still pending the approval of the Helsinki Committee, a medical panel that “is in charge of the authorization of human research and experiments”, to carry out the long-awaited trials.
The tests consist of three phases: the first will consist of evaluating the vaccine in a hundred healthy citizens between 18 and 50 years old.
The second phase will take place in December and will re-examine the safety and efficacy of the vaccine in 1,000 volunteers.
If positive results are obtained, the researchers will move on to the third stage, which will include some 30,000 human volunteers and is expected to take place from January.
The defense minister was also briefed on the process of developing antibodies designed to obtain medical treatment for the coronavirus.
According to current research, Israel has not been able to produce these antibodies on a commercial scale, and therefore negotiations are under way with a foreign company specializing in the field.
It is estimated that at least 1,000 antibodies could be developed by the first quarter of 2021.